Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This pilot study will make a preliminary determination of the safety of ustekinumab in
patients with Primary Sjogren's Syndrome (PSS) and assess the response of systemic measures
of inflammation (biomarkers).